Product analysis: no product was returned.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.Pma # is currently unavailable as the product model was not reported.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
Product analysis: upon receipt at medtronic¿s quality laboratory.Visual inspection revealed, fracture of the inner conductor wire at the proximal edge of the small distal electrode.This lead received extra excessive handling, as a tight knot including a piece of suture has been placed on the lead body and the inner connector pin has been broken off the proximal inner conductor.Conclusion: a device history record review could not be completed without the device lot identification.No electrical verification was performed, as only sections of products were returned.The returned product analysis indicates, that the surgeon elected to place a knot on the conductor wire, during implant surgery.The instruction for use for this device indicate, that the physician may choose to vary the lead fixation procedure in accordance with judgment and experiences such the selected fixation method should always allow for later pacing lead removal.The direction of the lead(s) should be chosen such that the electrode is in line with the rest of the lead body in order to allow smooth removal.It also states, do not excessively bend, kink, twist, or stretch the pacing lead.Excessive bending, kinking, twisting, or stretching may damage the junctions, pacing lead body and insulation.Resulting in device failure and /or loss of therapy.The fracture of the distal inner conductor then most probably occurred, due to fatigue related to flexing with the distal electrode in combination with, but not limited to, dislodgement.The position of the electrode in the heart tissue, the implant technique and the implant time.The fracture of the connector pin to proximal inner conductor, most probable root cause could be, due to excessive bending, kinking, twisting or stretching, during or post implant.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them, because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank, because the information is currently, unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|